A Change in Tack: The Government Turns its Attention Away from Pharmaceutical Companies and Toward Medical Device Manufacturers

A Change in Tack: The Government Turns its Attention Away from Pharmaceutical Companies and Toward Medical Device Manufacturers

At a recent conference on October 2, Susan Winkler, former Chief of the Health Care Fraud Unit for the District of Massachusetts, one of the most active offices for health care fraud in the country, stated that medical device firms will be the “new focus.” Prosecutors will investigate whether medical device manufacturers fairly and accurately report research results, or whether they instead suppress negative outcomes. Medical device companies should note this shift and review their protocols for reporting the results of studies. For more information or assistance with assessing how to report the results of investigative studies, please feel free to contact a member of Saul Ewing’s White Collar and Government Enforcement Group.

View Document(s):